Primary Cells vs. Cell Lines: Cloud-Clone Corp. Empowers Researchers to Choose the Optimal Path for Discovery

The Trade-off Between Physiological Authenticity and Experimental Convenience: Navigating the Cellular Foundation of ...
Taiwan News

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

Symptomatic response of obefazimod was observed as early as week 1 (first time point evaluated) with symptomatic remission observed at week 2 (nominally significant p-value <0.05) in a pooled analysis ...

Abalone Bio & Mount Sinai Researchers Publish Preclinical Data on First CB2 Antibody Agonists in Molecular Pharmacology

Peer-reviewed study characterizes in vitro and ex vivo activities of novel antibody agonists generated using Abalone ...

Is AI now threatening Software Companies?

Technology has underperformed the overall market and within the Technology sector, Software has been the worst performing industry.

TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years

Johnson & Johnson (NYSE: JNJ) today announced new long-term data from the QUASAR long-term extension (LTE) study showing that TREMFYA® (guselkumab) sustained clinical, endoscopic, and histologic ...